LiveKidney is a clinical-stage cell therapy company that develops proprietary, pharmaceutical grade, hydrogel-based formulations of umbilical cord Mesenchymal Stromal Cells (UC-MSCs) to treat advanced kidney disease and prevent its progression towards kidney failure.
The company' s products allow the continuous release of bioactive compounds from the UC-MSCs to the kidneys via unique routes of administration, triggering anti-inflammatory and anti-fibrotic effects through a systemic and local effect. Our pipeline of future products is based on our proprietary delivery platform and is designed to address a wide range of kidney-related diseases.
Company Details
Livekidney.bio Questions
Livekidney.Bio's website is https://livekidney.bio/homepage-2/
Livekidney.Bio's LinkedIn profile is https://www.linkedin.com/company/livekidney-bio
Livekidney.Bio has
5 employees.
View email and phone details for 5
employees at Livekidney.Bio.
Livekidney.Bio's industry is
Biotechnology Research
Livekidney.Bio's top competitors are
Biosight Ltd.,
Coverdolly Ltd,
Viritis Ltd,
Promarket,
Canopy Immunotherapeutics,
Quality Executive Partners, Inc. (Qxp®),
My Size, Inc. (Nasdaq: Mysz),
Butterfly Biosciences, Inc.,
Starkdale Farms,
L.raphael.
Livekidney.Bio's categories are Biotechnology Research
